Hong Kong Software Stock News

InSilico Medicine Cayman TopCo (SEHK:3696) reported that its AI-discovered drug rentosertib has progressed into Phase 3 clinical trials. New peer-reviewed studies on rentosertib indicate reversal of biological age in treated patients, based on multiple independent aging models. Global research collaborators are using rentosertib trials to build frameworks that embed aging biomarkers into idiopathic pulmonary fibrosis studies. The move of rentosertib into Phase 3, together with the reported...

Henderson Land Development recently drew attention after fresh analysis highlighted that its shares trade on a P/E ratio above both peer companies and the wider industry, prompting investors to reassess how the current market price aligns with the underlying property and development operations. A discounted cash flow model now suggests Henderson Land Development’s market valuation is well above its estimated intrinsic value, raising questions about how much future cash generation justifies...

Chinasoft International announced it won a RMB 35.5 million bid to build the Guangdong Industrial Robot and Smart Home Application Enablement Centre, extending its OpenHarmony based AI and IoT capabilities into Foshan’s large pan home furnishing manufacturing cluster. The project moves Chinasoft International from a pure technology service role toward operating an industry enablement platform that embeds its AI, device edge cloud and smart home expertise directly into a trillion RMB home...

Kingboard Laminates Holdings closed at HK$47.10 on Friday, up strongly over the past month even though the past week has been weak. The market came into this earnings print already paying a rich P/E of 33.8x, well above peers, so sentiment was leaning optimistic rather than cautious. The headline from these half year numbers is clear. Profitability has shifted sharply, with trailing net profit margin at 17.1% compared with 7.9% a year earlier and earnings over the past twelve months up 187%...

Xiaomi has seen its share price move sharply over recent years, and the question now is whether the current Hong Kong dollar price is justified by the cash flows the business can generate over time. With the stock recently closing at HK$26.40, investors are asking how much of the company’s cash flow story is already reflected in that number. Over the past 3 years, Xiaomi has delivered a 118.9% share price gain, which puts its current valuation under close scrutiny given the cash it is...

The market has barely flinched on NagaCorp, with the share price little changed over the past week even as fresh H1 2026 numbers put profitability in the spotlight. Net income of US$144.0m on US$293.7m in revenue keeps the business anchored in very high margin territory. That combination feeds straight into a low 5.9x P/E compared with Hong Kong hospitality peers that trade on much richer multiples. The key question for traders now is whether today’s muted move reflects a cool-headed focus on...

Shenguan Holdings came into this earnings season with a beaten up share price and a bargain label, trading around HK$0.25 while analysts see much higher value. The latest H1 2026 report undercuts that bargain story. Revenue sits at ¥455.957 million yet the business still posted a net loss of ¥44.863 million and basic earnings per share stayed in the red. For a stock priced on hope of a turnaround, another period of loss making operations keeps the spotlight firmly on profitability pressure...

GenFleet Therapeutics (Shanghai) closed at HK$25.9 after a choppy few months that left the stock down about 13% over 30 days and nearly 10% over 90 days. Today's headline is not about a sudden turnaround in profits. It is about whether investors accept a biotech story that is still deep in the red. The H1 2026 loss of C¥220.17 million and basic earnings per share of C¥0.59 in the red underline how early this commercial journey still is. What brings the longer-term view into focus is the...

Alibaba Health Information Technology appointed Yu Yong as chief executive officer and chairman in September 2026, consolidating leadership roles as former CEO Shen Difan shifted to focus on AI-driven healthcare solutions within the broader Alibaba Group while remaining engaged with Hydrion and digital tracking operations. Yu’s background in consumer e-commerce, merchant operations and supply chain transformation at Alibaba.com and 1688.com introduces a management style oriented around...

Yangtze Optical Fibre And Cable Limited (SEHK:6869) has confirmed an interim dividend of RMB 10.60 per 10 shares for the first half of 2026, with payment expected by November 10. The interim dividend news lands after a sharp re‑rating of Yangtze Optical Fibre And Cable Limited. A 30‑day share price return of 26.13% and a year to date share price gain of 251.91% contrast with a 90‑day share price decline of 15.34% and a very large 3‑year total shareholder return that signals momentum built...

Amidst a backdrop of geopolitical tensions and fluctuating oil prices, Asian markets continue to navigate a complex economic landscape. For investors looking beyond the major indices, penny stocks—though an outdated term—still hold potential for growth, particularly in smaller or newer companies. These stocks can offer unique opportunities when they are supported by strong financial health and solid fundamentals, making them worth considering for those seeking diversified investment options.

Amidst global market volatility driven by geopolitical tensions and rising oil prices, Asian small-cap stocks have emerged as intriguing prospects for investors seeking growth opportunities. In this environment, identifying companies with strong fundamentals and the ability to navigate economic uncertainties is crucial, making Auntea Jenny Shanghai Industrial and two other promising small-cap gems in Asia worth exploring.

China Shenhua Energy (SEHK:1088) drew investor attention after a recent price move that left the stock down 1.1% on the day but still higher over the past month and past 3 months. For context, China Shenhua Energy is trading at HK$44.72, with the share price down over the past week but still ahead over the past quarter and year to date, while the 1 year, 3 year and 5 year total shareholder returns of 24.72%, about 2.2x and about 3.9x respectively point to longer term momentum that recent...

Everest Medicines announced that its subsidiary Everest Medicines China signed a Strategic Cooperation Framework Agreement with Hasten Biopharmaceutical covering supply, distribution, manufacturing and commercialization of multiple products in the PRC through to at least 2028. The framework sets sizeable annual transaction caps, introduces several commercial and manufacturing models, and aims to use Everest Medicines' planned GSP distribution platform to work with Hasten's product portfolio...

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Minth Group (SEHK:425) has drawn fresh attention after recent trading left the share price around HK$24. Returns over the past month and past 3 months have both shown double digit declines. The recent drop has left Minth Group with a 30-day share price return down 15.6% and a 90-day share price return down 18.7%, while the year-to-date share price return is down 28.7% and the 1-year total shareholder return is down 30.7%. However, the 3-year total shareholder return remains positive at 23.3%,...

A new wave of potential mega-IPOs around AI and space is turning equity capital markets into front-page news again, and you do not need to be an investment banker to care. Big offerings can reshape fee pools, deal pipelines and investor attention, which can reward some listed intermediaries more than others. This article walks through 3 stocks exposed to that IPO story and explains why each might deserve a closer look now. The three stocks below are just a sample, and the full screen surfaced...

While it’s been a great week for MS Group Holdings Limited ( HKG:1451 ) shareholders after stock gained 19%, they...

Last week, Platt Nera International Limited ( HKG:1949 ) insiders, who had purchased shares in the previous 12 months...

Shanghai Forest Cabin Cosmetics Group Co., Ltd. ( HKG:2657 ) is about to trade ex-dividend in the next four days. The...

Insiders who bought Zhong Jia Guo Xin Holdings Company Limited ( HKG:899 ) stock in the last 12 months were richly...

China Resources Power Holdings has delivered a solid run for patient shareholders, so the real issue now is whether the current share price lines up with the dividend stream that investors are paying for. With the stock moving over several timeframes, the question is how much of that performance the present dividend profile can realistically justify. Over the past 3 years, China Resources Power Holdings has returned 50.8%, which puts real weight on whether the dividend track and payout...

As geopolitical tensions and inflation concerns continue to shape global markets, investors are increasingly seeking opportunities that balance risk with potential reward. Penny stocks, though often seen as a throwback to earlier trading days, remain a compelling area for those looking to uncover value in smaller or newer companies. By focusing on financial strength and growth potential, these stocks can offer affordability alongside the possibility of significant returns.

Wharf Real Estate Investment Company Limited declared a first interim dividend of HK$0.94 per share, up from HK$0.66, with a HK$2.854b distribution paid on 10 September 2026, equal to 90% of underlying net profit from Hong Kong investment properties and hotels. The decision to return such a high share of underlying profit to investors highlights that Wharf Real Estate Investment is prioritising cash distribution from its core Hong Kong assets instead of retaining more earnings for...